Open access

Lactic Acid Bacteria as Source of Functional Ingredients

Written By

Panagiota Florou-Paneri, Efterpi Christaki and Eleftherios Bonos

Submitted: 16 November 2011 Published: 30 January 2013

DOI: 10.5772/47766

From the Edited Volume

Lactic Acid Bacteria - R & D for Food, Health and Livestock Purposes

Edited by Marcelino Kongo

Chapter metrics overview

8,256 Chapter Downloads

View Full Metrics

1. Introduction

Lactic acid bacteria (LAB) are widespread microorganisms which can be found in any environment rich mainly in carbohydrates, such as plants, fermented foods and the mucosal surfaces of humans, terrestrial and marine animals. In the human and animal bodies, LAB are part of the normal microbiota or microflora, the ecosystem that naturally inhabits the gastrointestinal and genitourinary tracts, which is comprised by a large number of different bacterial species with a diverse amount of strains [1,2].

Phylogenetically the LAB belong to the Clostridium branch of Gram positive bacteria. They are non-sporing, aero tolerant anaerobes that lack catalase and respiratory chain, with a DNA base composition of less than 53 mol% G+C [3,4]. According to their morphology LAB are divided to robs and cocci and according to the mode of glucose fermentation to homofermentative and heterofermentative. The homofermentative LAB convert carbohydrates to lactic acid as the only or major end-product, while the heterofermentative produce lactic acid and additional products such as ethanol, acetic acid and carbon dioxide [5,6]. Thus, the main metabolism of LAB is the degradation of different carbohydrates and related compounds by producing primarily lactic acid and energy. Although many genera of bacteria produce lactic acid as primary or secondary fermentation products, typical lactic acid bacteria are those of the Lactobacillales order, including the following genera: Lactobacillus, Carnobacterium, Lactococcus, Streptococcus, Enterococcus, Vagococcus, Leuconostoc, Oenococcus, Pediococcus, Tetragonococcus, Aerococcus and Weissella [7].

Many strains of LAB are among the most important groups of microorganisms used in the food and feed industries, although some of the genus Pediococcus cause deterioration of foods, which results in their spoilage [4]. LAB have been used in food preservation and for the modification of the organoleptic characteristics of foods, for example flavors and texture [2]. Various strains of LAB [8] can be found in dairy products (yoghurt, cheese), fermented meats (salami), fermented vegetables (olives, sauerkraut), sourdough bread, etc [9]. The European Food Safety Authority (EFSA) has stated that several LAB strains can be considered to have “Qualified Presumption of Safety” QPS-status [9].

Moreover, nowadays, LAB play an important role in the industry for the synthesis of chemicals, pharmaceuticals, or other useful products (Figure 1). Also, the biotechnological production of lactic acid has recently reported that offers a solution to the environmental pollution by the petrochemical industry [10].

Figure 1.

Uses and Functional Ingredients of Lactic Acid Bacteria

This chapter will discuss recent applications of LAB as source of probiotics, starter cultures, antimicrobial agents, vitamins, enzymes and exopolysaccharides, especially those that can satisfy the increasing consumer’s demands for natural products and functional foods in relation with human health.


2. Lactic acid bacteria as source of probiotics

Etymologically the term probiotics is derived from the Greek “probios” which means “for life”. In 1974 Parker [11] defined as probiotics “organisms and substances which contribute to intestinal microbial balance”. Fuller in 1989 [12] defined as probiotic “a live microbial feed supplement which beneficially affects the host animal by improving its intestinal microbial balance”. Later the Food and Agriculture Organization / World Health Organization defined probiotic bacteria as “live microorganisms which when administered in adequate amounts confer a health benefit on the host” [13]. Since probiotics can colonize the gastrointestinal tract and exert their beneficial effect long term, without requiring continuous medical intervention, they have been used for a century to treat a variety of mucosal surface infections (gut, vagina), but their use decreased after the appearance of antibiotics. However, today, probiotics are considered as an alternative solution to antibiotics due to the increasing spread of antibiotic resistance and the need for treatment cost reduction [14].

Microorganisms considered as commercial probiotics are mainly of the Lactobacillus genus with over one hundred species recognized, for example: L. acidophilus, L. rhamnosus, L. reuteri, L. casei, L. plantarum, L. bulgaricus, L. delbrueckii, L. helveticus [15-17]. Lactobacilli are Generally Recognized As Safe (GRAS) organisms [18,19].

Probiotic bacteria are very sensitive to many environmental stresses, such as acidity, oxygen and temperature [20,21] and they must fulfill some functional and physiological aspects such as [21,22]: a) Adherence to the intestinal epithelium and colonization of the lumen of the tract. b) Ability to stabilize the intestinal microbiota. c) Counteracting the action of harmful microorganisms. d) Production of antimicrobial substances. e) Stimulation of the immune response.

There are subcategories of the general term probiotic [23,24] which are: a) Probiotic drugs: intended to cue, treat and prevent disease. b) Probiotic foods: food ingredients and dietary supplements. c) Direct-fed microbials: probiotics for animal use. d) Designer probiotics: genetically modified. Generally, foods containing probiotic bacteria fall in the category of functional foods [25].

2.1. Mechanism of action of probiotics

Probiotics have multiple and diverse effects on the host. The main mechanisms of action of probiotic bacteria by which they improve mucosal defenses of the gastrointestinal tract include:

  1. Antimicrobial activity: The probiotics block the colonization of pathogenic bacteria by decreasing luminal pH, inhibiting bacterial invasion and adhesion to epithelial cells and producing antimicrobial compounds such as bacteriocins and defensins, organic acids and hydrogen peroxide. The interaction of LAB with the mucosal epithelial cells of the gastrointestinal tract and the lymphoid cells in the gut enhance the gut immune response against ingested pathogens [26,27].

  2. Enhancement of mucosal barrier function against ingested pathogens: It is achieved with the increasing mucus production through modulation of cytoskeletal and tight junctional protein phosphorylation. The probiotic bacteria compete with pathogenic bacteria for epithelial binding sites, inhibiting the colonization of strains like Salmonella and E. coli [28,29]. Probiotic bacteria interact with the epithelial cells of the gut, either directly (via cell compounds like DNA, lipoteichoic acids and cell-surface polysaccharides) or indirectly (through production of bioactive metabolites) [30]. The enhancement of mucosal barrier function may be an important mechanism by which probiotics benefit the host in various diseases such as Type 1 diabetes [31,32].

  3. Immunomodulation: Specific strains of probiotics might influence the innate and the acquired immune system, thus playing an important role in human diseases. Probiotic bacteria may affect the epithelial cells, the dendritic cells, the monocytes / macrophages and the various types of lymphocytes (Natural killer cells, T-cells and T-cell redistribution) directly or secondarily [33,34]. This action of probiotics could be important for the elimination of neoplastic host cells [22]. Moreover, the effects of probiotics on B-lymphocytes and antibody production resulted in an increase in IgA secretion and the enhancement of response to vaccination [34]. Recently, it was also reported that probiotics can have positive effects on the respiratory system by preventing and reducing the severity of respiratory infections, because of an increase of IgA in the bronchial mucosa [35].

2.2. Probiotics and health

Functional properties of probiotics have been demonstrated for various therapeutic applications. Nevertheless, the health benefits provided by probiotics are strain-specific, therefore no probiotic strain will have all proposes benefits, not even strains of the same species [36]. Among the LAB probiotic strains L. rhamnosus GG and L. casei Shirota have the strongest human health efficacy in the management of lactose intolerance, rotaviral diarrhea and antibiotic associated diarrhea [17]. An optimal single oral dose, based on detection of the bacteria in human feces is 109 bacterial colony forming units (CFU) [37], while in other reports 106-107 CFU / g of food are considered adequate amounts [13,17,38].

Moreover, in animal nutrition dietary probiotics or direct fed microbials, term which is preferred in the USA, are able to help the maintenance of a healthy intestinal microflora. This microflora may serve to improve performance and health status of the animals, but also to suppress food born pathogens such as Salmonella and Campylobacter. These conditions are necessary for the production of safe meat and meat products [39]. For instance, the gastrointestinal tract of broilers can be colonized by ingested probiotic bacteria from the first days of their life, which results in shorter period for the achievement of microflora stability. Also, in another example the dietary inclusion of probiotics in young calves’ milk replacers may improve their growth performance [40].

Some of the beneficial effects of probiotics are well established as shown in Table 1.

Lactic Acid BacteriaEffects on human healthReferences
Lactobacillus rhamnosus GGMay shorten the course of rotavirus causing diarrhea.
Helps to alleviate the symptoms of ulcerative colitis and atopic dermatitis.
Lactobacillus caseiReduces the severity and duration of diarrhea. It can stimulate the immune system of the gut and alleviates the symptoms of Crohn’s disease17, 43, 46
Lactobacillus acidophilusSecretes lactic acid which reduces the pH of the gut and inhibits the development of pathogens (Salmonella spp, E. coli).
Reduces blood cholesterol.
17, 46, 47
Lactobacillus johnsoniiEffective in inhibition of H. pylori and against inflammation17, 36
Lactobacillus plantarumProduces short-chain fatty acids that block the generation of carcinogenic agents by reducing enzyme activities17, 36
Lactobacillus fermentumEffective in restoration of a normal microflora. Effective against bacterial vaginosis flora48
Lactobacillus reuteriReduces the duration of diarrhea49
Enterococcus faeciumCan reduce blood cholesterol leading to decreased blood pressure50-52

Table 1.

Lactic acid bacteria derived probiotics and human health

LAB derived probiotics have potential health benefits in the following situations:

  1. Diarrheal diseases:

    1. Infective diarrhea. The most studied gastrointestinal condition treated by probiotics is acute infectious diarrhea in infants. Children represent a main target of studies due to the importance of limiting the spread of diseases and decreasing the need of antibiotics (Aureli et al. 2011). Clinical trials with LAB derived probiotics (L. rhamnosus GG; L. reuteri; L. casei; L. delbrueckii subsp. Bulgaricus) support the efficacy of these probiotics in preventing diarrhea [14,49,53], due to their direct or indirect interaction with the enterotoxins [54].

    2. Antibiotic associated diarrhea. A variety of probiotic bacteria, mainly lactobacilli have been used in the treatment and prevention of antibiotic associated diarrhea [55,56]. In a recent study L. acidophilus and L. casei seemed to be effective in reducing the risk of development of diarrhea [57]. Nevertheless, the results obtained were from pilot studies, so further investigation is needed to evaluate the efficacy of probiotics on such disorders.

    3. Clostridium difficile associated diarrhea. C. difficile is an opportunistic pathogen often responsible for diarrhea in vulnerable people. L. rhamnosus GG, has demonstrated positive effects on treated patients [14].

    4. Travelers diarrhea. Probiotics with Lactobacilli did not seem to be effective on such diarrhea, which is caused by bacteria, in particular enterotoxigenic E. coli [14,53].

    5. Radiation induced diarrhea. Although there is little research on this subject, probiotics seem to be promising in decreasing radiation diarrhea [53].

  2. Inflammatory bowel disease

    LAB may affect positively the intestinal mobility and relieve constipation, possibly through a reduction of the intestinal pH [58].

    1. Pouchitis. It is a chronic inflammation of the ileal pouch. The treatment with probiotics such as L. rhamnosus GG and L. acidophilus reduced the risk of pouchitis due to decreased mucosal inflammation [59,60].

    2. Crohn’s disease. This disease can involve the whole gastrointestinal tract and is characterized by inflammatory processes occurring deeper in the tissues. Among other typical treatments L. rhamnosus is used aiming at decreasing the rate and the severity of disease after surgery [61].

    3. Ulcerative colitis. It is an acute or chronic disease only affecting the large bowel. LAB probiotics (L. acidophilus) provide some promising initial indications [53].

  3. Irritable bowel syndrome

    This term is used to describe a heterogenous group of gastrointestinal symptoms, like diarrhea, constipation, bloating and abdominal pain. L. plantarum strain 299V and E. faecium PR88 could be effective treatments against this syndrome [62,63].

  4. Prevention of colon cancer

    The anticarcinogenic effect of probiotiocs may be attributable to a combination of mechanisms like the induction of pro- or anti-inflammatory and secretary responses that could inhibit carcinogenesis [22]. In vitro studies with lactobacillus strains have shown anti-mutagenic activities. However, there is no evidence yet that probiotics can protect against the development of colon cancer in humans [64,65]. Although, it is hypothesized that the strains tested may have anti-carcinogenic effects by reducing the activity of the enzyme β-glucuronidase.

  5. Helicobacter pylori

    It is a common chronic bacterial infection in humans, which causes many problems, such as chronic gastritis, septic ulcers and gastric cancer. Probiotics like L. salivarius, L. casei Shirota and L. acidophilus appear to be promising in inhibiting the growth of H. pylori in vitro [66,67]. Moreover, L. johnsonii was also shown effective to inhibit H. pylori [68].

  6. Lactose intolerance

    It is the most common disorder of the intestinal carbohydrate digestion. In both adults and children it has been shown that probiotics can improve the lactose digestion by reducing the intolerance symptoms and slowing orocecal transit [69,70].

  7. Blood cholesterol

    Recently it has been suggested that some strains of probiotic bacteria, like L. acidophilus, L. plantarum and Enterococcus faecium could significantly reduce blood cholesterol and increase resistance of low density lipoprotein oxidation, leading to decrease of blood pressure [50-52].

  8. Other disorders

    The majority of probiotics use has focused on diseases related to the gut, but there are studies that evaluated probiotics, in allergic conditions, including atopic dermatitis, rhinitis, bacterial vaginosis and food allergies [53,71].

    1. Atopic Dermatitis. It is the most common of the chronic skin disorders, known as eczema. Investigations have shown that probiotics like L. rhamnosus GG, can prevent or reduce the symptoms [42]. Even eczema can be prevented if mothers ingest probiotics during pregnancy and neonatals ingest them during the first 6 months of their life [53].

    2. Bacterial Vaginosis. Probiotics (L. rhamnosus GR-1 and L. fermentum RC-14) are considered to have theraupetic benefits in vaginosis. Probably this is due to the large numbers of lactobacilli in the healthy vaginal microflora [72,73].

    3. Other ailments. Probiotics such as Lactococcus, Pediococcus and Leuconostoc can prevent or limit mycotoxinogenic mould growth [74-78]. Moreover, LAB according to their bacterial strain could bind aflatoxin B1 both in vivo and in vitro [79]. It was reported in studies that L. paracasei ST11 reduced body and abdominal fat [80]. These probiotic bacteria seemed to have an anti-obese action. Probably intestinal bacteria may regulate body weight by affecting the host’s metabolic neuroendocrine and immune functions [80]. Additionally, probiotics may have anticariogenic effects, preventing and treating dental caries and generally be effective in the oral cavity and the treatment of periodontal disease [81,82].


3. Lactic acid bacteria as source of starter cultures

3.1. Starter cultures and functional starter cultures in fermentation of foods

LAB for a long time have been applied as starter cultures in fermented foods and beverages, because they can improve nutritional, organoleptic, technological and shelf-life characteristics [83,84]. LAB initiate rapid and adequate acidification in the raw materials, through the production of various organic acids from carbohydrates. Lactic acid is the most abundant, followed by acetic acid, whilst LAB can also produce ethanol, bacteriocins, aroma compounds, exopolysaccharides and some enzymes [85]. Earlier the production of fermented foods and beverages was obtained on a spontaneous fermentation, due to the microflora naturally present on the raw materials. Later on, the direct addition of selected starter cultures to the food matrix was preferred by the food industry. The advantages were the high degree of control over the fermentation process and the standardization of the final product [84].

As starter culture can be defined a microbial preparation of a large number of one or more microorganisms which is introduced to a raw material aiming to produce a fermented food by accelerating and steering its fermentation process [86,87].

The industries of fermented foods mainly utilize commercial starter cultures for the direct inoculation to the food matrix, which are available as frozen and freeze dried concentrates or lyophilized preparations [88].

Recently the use of functional starter cultures in food and beverage fermentation is being explored. These cultures have at least one functional property, contributing in the improvement of the fermentation process, enhancing the quality and of the end safety product and conferring health benefits [84]. Nevertheless, the selection of starter cultures must also eliminate undesirable side effects like the formation of D-lactic acid or a racemate of lactic acid (DL) or the formation of biogenic amines [84,89].

3.2. Probiotics as functional starter cultures

A category of successful starter cultures are LAB produced probiotic cultures. Firstly, Metchnikoff [90] discovered the beneficial effects of LAB on human health, through the consumption of yoghurts and fermented milks. Currently probiotic cultures are used for a number of products such as yoghurt, yoghurt drinks, infant formulas, dietary supplements, etc [91]. Yoghurt is manufactured using Streptococcus thermophilus and Lactobaccilus delbrueckii subsp. bulcaricus as starter cultures [17].

A manufacture in order to choose any probiotic microbial strain to be used as starter culture or better as a blend with a traditionally used starter culture (co-culture), must check the following aspects [92]: 1) The ability of the probiotics to grow in a medium to increase the cells counts. 2) The robustness of the organism to withstand the freezing and drying stages of preparation. 3) The tolerance to acidity of the gastric acid and the bile salts during their passage in the gastrointestinal tract. Thus, the probiotic strains must be stable in order to claim the health benefits [92].

LAB are used as starter cultures either in dairy or non-dairy products (Table 2).

GenusApplication in dairy foodsApplication in non-dairy foods
Lactobacillus sppCultured dairy products, cheese, yoghurt, kefirSausage, sourdough bread, fermented vegetables
Lactococcus sppCheese, butter milk sour cream, cultured dairy products-
Leuconostoc sppCheese, cultured dairy products, sour cream, buttermilkFermented vegetables
Streptococcus thermophilusCheese, yoghurt -
Pediococcus-Sausage, fermented vegetables
Tetragenococcus-Soy sauce

Table 2.

Lactic acid bacteria used as starter cultures in fermented foods

3.3. Functional starter cultures in fermented dairy products

Traditionally, LAB have been used in the fermentation of dairy products, as a simple and safe way of preserving such foods. The main species of LAB that can potentially be used as probiotic cultures in dairy products belong to the Lactobacillus spp (L. acidophilus, L. lactis, L. casei, L. plantarum, L. rhamnosus, L. reuteri, L. delbrueckii subsp. bulgaricus) or to the Enterococcus spp. (E. faecalis, E. faecium) [17,92].

Dairy products are considered as ideal vehicles for delivering probiotics to the human gut. Yoghurt is considered the most important, followed by cultured buttermilk, kefir, cheeses, ice-cream [17,22,92] or frozen desserts like chocolate mousse [93]. Moreover proteolytic strains of LAB produced probiotics are used to release bioactive peptites called angiotensin I-converting enzyme inhibitors, which are examined for their hypotensive role [94]. Furthermore interaction between probiotics and starter cultures are possible, either as synergism (e.g. yoghurt) or antagonism (e.g. bacteriocins which exhibit antibiotic properties) [20].

A minimum viable LAB count of 106 CFU/g in fermented dairy food is recommended for the claimed health benefits [95].

3.4. Functional starter cultures in fermented non-dairy products

3.4.1.Fermented meat and meat products

The preservation of meat and meat products by fermentation has been used from ancient times and it was based mainly on natural meat microorganisms. Recently, researchers begun to develop starter cultures for meat products, in order to ensure standard quality for the fermentation process [87]. In 1995 the first LAB meat starter culture used by Niven et al. [96] in the USA was a pure culture of Pediococcus cerevisiae. Essential requirements of meat LAB starter cultures are the immediate and rapid production of organic acids at the start of the fermentation, which will result in a pH below 5.1 [97]. Therefore, the original characteristics of the foods are changed, resulting in enhancement of the final products [98].

As commercial meat LAB starter cultures the species more used belong to the Lactobacillus and Pediococcus strains, which can be isolated from dry sausages [97], sauerkraut [20], or smoked salmon [99]. Strains of the above LAB were found to have the best survival activity under acidic conditions and high levels of bile salts [98]. The role of the starter culture as aforementioned is for the safety of foods by inactivating pathogens and spoilage microorganisms via the acid and bacteriosin production. Therefore, the production of biogenic amines is inhibited and microbial growth is suppressed, without the use of antibiotics [97].

Several studies have reported that LAB from meat and meat products can have antibiotic resistance [100]. Thus, before using novel starter cultures or probiotic cultures it is important to check that they do not contain transferable resistance genes [97]. In addition, the selection of LAB starter cultures for sausage production must not have amino decarboxylase activity. Otherwise, biogenic amines will be produced in foods, such as histamine, tryptamine, tyramine, cadaverine, putrescine and phenylethylamine which have toxic effects [101].

3.4.2. Fermented vegetables

LAB fermentation of vegetables can be achieved due to the presence of carbohydrates. Usually fermented vegetable juices are produced from cabbage, red beet, carrot, celery and tomato [18,102]. Also, LAB play an important role in pickles and table olives fermentation, affecting the final flavour and shelf-life [103,104].

3.4.3. Starter cultures in silages

Ensiling is a traditional method of preserving forages and is widely used all over the world. It is based on natural fermentation, where LAB ferment water-soluble carbohydrates into organic acids, mainly lactic acid or acetic and formic acids, under anaerobic conditions. Inoculation of LAB is often used as silage additive to enhance lactic acid fermentation [18]. This results in decreasing pH, inhibiting detrimental anaerobes and preserving the nutritional value and palatability of the forage [105,106].

Among the LAB genera frequently used are Lactobacillus plantarum, Enterococcus faecium, Pediococcus acidilactici, Pediococcus pentoseceus and Lactobacillus acidophilus, with usual rates 105-106 viable cells / g [107]. Feeding ruminants with silages that have been treated with LAB beyond improving their performance, it is believed to induce probiotic effects [108].


4. Lactic acid bacteria as source of antimicrobial agents

LAB derived probiotic bacteria display a wide range of antimicrobial activities. Some strains of LAB produce non specific antimicrobial substances (short chain fatty acids, hydrogen peroxide) while others produce toxins (bacteriosins, bacteriosin-like components) [109]. Short chain fatty acids (formic, acetic, propionic, butyric and lactic acids) which are produced during the anaerobic metabolism of carbohydrates, decrease the pH. It has been considered that these acids are responsible for the domination of mucosal ecosystems by LAB [110]. Also, hydrogen peroxide inhibits the growth of pathogens [111].

4.1. Bacteriocins

Most of bacteriocins originating by Gram positive bacteria are produced from LAB. They are proteins that have bacteriocidal activity against species closely related to the bacteriocin producing strains, which could be applied in food preservation and health care [112,113]. Traditionally bacteriocin production has been considered an important characteristic in the selection of probiotic strains, while nowadays it is considered that they may function within the gastrointestinal tract [114], perhaps as alternatives to antibiotics for medical and veterinary use [115]. Generally bacteriocins are cationic peptides which display hydrophobic or amphilitic properties and usually the bacterial membrane is the target for their action [116].

The majority of bacteriocin produced by LAB are distinguished from classical antibiotics because: a) They are ribosomally synthesized and have a relatively narrow killing spectrum. b) They can be divided into two main groups, produced by Gram-negative and Gram-positive bacteria [117,118].

Bacteriocins according to their structure and characteristics can be classified mainly in the following classes:

  • Class I (lantibiotics), small peptides [119].

  • Class II, small heat-stable proteins which are further divided into subclasses such as IIa (pediocin-like bacteriocins) and IIb (two peptite bacteriocins) [119].

  • Class III (helveticin) [120].

Bacteriocins mainly produced by Lactobacillus acidophilus have strong antimicrobial capacity against various food pathogens [113]. Bacteriocins can act as bactericidal or bacteriostatic, a distinction which is strongly dependent on bacteriocin dose and degree of purification, physiological state of the indicator cells and experimental conditions such as incubation temperature, pH, presence of agents disrupting cell wall integrity, etc [121,122].

4.2. Traits of LAB derived bacteriocins

LAB derived bacteriocins are suitable to use as food preservatives due to their characteristics: a) protein nature – they are inactivated by proteases in the gastrointestinal tract. b) Non-toxic and generally non-immunogenic. c) Thermoresistant thus the antimicrobial activity remains after pasteurization and sterilization. d) Affect most of the Gram-positive bacteria. e) Genetic determinants generally located in plasmid facilitating genetic manipulation to increase the variety of natural peptides. f) Usually act on the bacterial cytoplasmic membrane having no cross resistance with antibiotics [122,123].

Some benefits of the use of bacteriocins as food preservatives are: a) extended shelf-life of foods. b) reduction of the risk of transmission of food born pathogenic bacteria. c) Amelioration of economic losses due to food spoilage. d) No addition of chemical preservatives. e) Decrease of the intensity of heat treatments resulting in better preservation of food nutrients and sensory properties of the food. f) Marketing of “novel” foods, less acidic, less salty and with higher water content [123].

Nicin (lantibiotic – class I) is the first bacteriosin produced by LAB (Lactococcus lactis) whilst today it is used in many countries as biopreservatives in foods [109]. Nicins have a dual mode of action: a) Binding to lipid II thus preventing correct cell wall synthesis and b) employing lipid II as a docking molecule to initiate a process of membrane insertion and pore formation which leads to rapid cell death [109]. Nisin-producing bacteria can be found in about 30% of human milk samples. This substance may protect mothers from mastitis and infants from toxication by pathogenic skin flora like Staphylococcus aureus [124]. Except from nicin, currently pediocin PA-1/AcH from several Pediococcus strains and enterocin AS-48 from Enterococcus faecalis are used as biopreservatives [119].

There are at least three ways in which bacteriocins can be incorporated into a food to ameliorate its safety: a) By using a purified or semi-purified bacteriocin preparation as food ingredient. b) By introducing an ingredient that has earlier been fermented with a bacteriocin producing strain. c) By using a bacteriocin-producing culture in fermented products to produce the bacteriocin in situ [125].

Additionally, bacteriocin production can contribute to the probiotic functionality of intestinal LAB, while in certain cases may be directly responsible for it, with respect to either beneficially modulating the gut microbiota or inhibiting some gastrointestinal pathogenic bacteria [30].

Consequently bacteriocins, derived from LAB can cover a broad field of applications, including the food industry and the medical sector, mainly in combination with other treatments to increase their effectiveness in humans and animals [126]. In the latter, bacteriocins can be used as growth promoters, instead of antibiotics, which have been banned in the European Union since 2006 [127].


5. Lactic acid bacteria as source of vitamins

Human life cannot exist without vitamins, because they are involved in essential functions e.g. cell metabolism and antioxidant activities. Humans cannot synthesize most of these vitamins, although it is well known that some intestinal bacteria like LAB can produce some vitamins (folate, vitamin B12 or cobalamin, vitamin K2 or menaguino, riboflavin and thiamine) [128,129]. The gut microbiota has been recognized as a source of some water-soluble vitamins, while such vitamins have also been reported as results of the LAB fermentation in yogurt, cheeses and other fermented foods.

5.1. Folate

Folate is the term used to describe the folic acid derivatives, such as the folyl glutamates which are naturally present in foods and folic acid that is the chemically synthesized form of folate, commonly used for food fortification and nutritional supplements. Folate belongs to the B-group of vitamins and participates in many metabolic pathways like the biosynthesis of DNA and RNA and the inter-conversions of amino acids. Moreover, folate possesses antioxidant capacity that protects the genome by preventing free radical hack of DNA [130].

Dietary folate is essential for humans, since it cannot be synthesized by mammalian cells. Folate can be found in legumes, leafy greens, some fruits and vegetables, in liver and fermented dairy products [131], especially in yogurts, where it may be increased depending on the starter cultures used and the storage condition, to values above 200 μg / lt [132]. Epidemiological studies indicated that folate deficiency is associated with a variety of disorders like Alzheinmer’s disease, coronary heart diseases, osteoporosis and increased risk of breast and colorectal cancer [130,133].

LAB having the ability to produce folate belong to the Lactobacillus spp (L. lactis, L. plantarum, L. bulgaricus), Streptococcus spp. and Enterococcus spp. Nevertheless, some lactobacilli strains (L. gasseri, L. salivarius, L. acidophilus and L. johnsonii) used as both starter cultures and probiotics, cannot synthesize folate due to their lacking in some genes involved in folate biosynthesis [130]. Furthermore, it has been reported that some starter cultures and probiotic lactobacillus strains in non-dairy foods utilize more folate than they produce [128,130]. For this reason nowadays the food industry focuses on the strategy to select and use folate producing probiotic strains, to produce fermented products with elevated amounts of “natural” folate concentrations, without increasing production cost, although increasing health benefits [130,133].

5.2. Vitamin B12

Vitamin B12 or cobalamin is required for the metabolism of fatty acids, amino acids, nucleic acids and carbohydrates [134]. Vitamin B12 cannot be synthesized by mammals and must be obtained from exogenous sources like foods or the intestinal microbiota [128]. It has been reported that among the microorganisms some members of the Lactobacillus spp have the ability to produce this vitamin. In particular a probiotic strain of L. reuteri which exhibits hypocholesterolaemic activity in animals can produce B12 [135].

Vitamin B12 deficiency can cause various pathological disorders that affect the haematopoietic (pernicious anaemia), nervous and cardiovascular system. Furthermore, this deficiency in male animal models influenced the number of offspring which showed growth retardation and decrease in some blood parameters [136].

5.3. Vitamin K

Vitamin K is involved in blood clotting, tissue calcification, atherosclerotic plaque and bones and kidneys function [137]. Vitamin K is present as phylloquinone (Vitamin K1) in green plants and as menaquinone (K2) produced by some intestinal bacteria, like LAB and especially strains of the genera Lactococcus, Lactobacillus, Enterococcus, Leuconostoc and Streptococcus [128]. Vitamin K deficiency has been involved in some clinical disorders like intracranial hemorrhage in newborn infants and possible bone fracture resulting from osteoporosis [129]. LAB producing menoquinone could be useful to supplement vitamin K requirements in humans [138].

5.4. Riboflavin

Riboflavin or vitamin B2 is necessary in cellular metabolism, being the precursor of coenzymes acting as hydrogen carriers in biological redox reactions [129]. Although, riboflavin is present in many foods such as dairy products, meat, eggs, green vegetables, its deficiency occurs with damages in the liver, skin and changes in the brain glucose metabolism [128,129], with symptoms like hyperaemia, sore throat, odema of oral and mucous membranes, cheilosis and glossitis [139].

Currently, riboflavin-producing LAB strains were isolated and used as a convenient biotechnological application for the preparation of bread (fermented sourdough) and pasta to enrich them with vitamin B2 [140].


6. Lactic acid bacteria as source of enzymes

LAB possess an extensive collection of enzymes many of which have the potential to influence the composition and the processing, organoleptic properties and quality of foods and feeds. LAB release various enzymes into the gastrointestinal tract and exert potential synergistic effects on digestion and alleviate symptoms of intestinal malabsorption [141]. In other cases these organisms may serve as a source for the preparation of enzyme extracts that are able to function under the environmental conditions of fermentation [142]. The enzymatic activity has been studied mainly in LAB isolated from wine or other fermented foods like cheeses and yoghurt [143,144]. Species of Lactococcus and Pediococcus are the LAB most commonly associated with fermented foods [143]. The LAB produced enzymes and in particular amylases which are the most stable can be used in sourdough technology for the natural improvement of bread texture [145]. Moreover, LAB contribute to the aroma and flavor of fermented foods. Certain peptidases produced by Lactococcus lactis subsp. cremoris improved the sensory quality of cheese [146]. In addition, proteolysis and lipolysis may enhance the flavour of most varieties of cheese [147]. LAB strains isolated from a traditional Spanish Genestoso cheese were evaluated for the enzymatic activity and it was reported that dipeptidase activity of high level was found for Lactococcus spp, enterolytic activity was detected for Enterococcus spp., while carboxypeptidase activity was very low or undetectable [147].

Also, enzymes play an important role in winemaking. Wine flavor and aroma apart from aromas originating in grapes and alcoholic fermentation, is derived mainly from the activity of the LAB, through the action of their enzymes. These bacteria grow in wine during malolactic fermentation, following alcoholic fermentation, while a broad range of secondary modifications improve the taste and flavor of wine [144].


7. Lactic acid bacteria as source of exopolysaccharides

7.1. Definition and classification of exopolysaccharides

A number of LAB can produce a variety of long chain sugar polymers, called exopolysaccharides (EPS) which are mainly employed for the production of fermented dairy products. They are synthesized either extracellularly from sucrose by glycansucrases or intracellularly by glycosyltransferases from sugar nucleotide precursors [148]. These EPS can be classified according to their chemical composition and biosynthesis mechanism as homopolysaccharides, consisting of a single type of monosaccharide and heteropolysaccharides consisting of repeating units of two or more types of monosaccharides, substituted monosaccharides and other units like phosphate, acetyl and glycerol [149-151].

Homopolysaccharides are further divided into fructans including levan and inuline-type and glucans including dextran, mutan, alteran and b-1, 3 glucan [152]. On the other hand, heteropolysaccharides demonstrate little structural similarity to one another. Their production is influenced by the bacterial growth, phase, medium composition (carbon and nitrogen source), pH and temperature [153]. They can be produced by Lactococcus spp. and Lactobacillus spp. and they play a crucial role in the food industry [151]. Homopolysaccharides can be introduced in sourdough products, influencing the structural quality and backing ability in bakery products, while heteropolysaccharides are used as food additives in dairy products [154]. EPS contribute to the organoleptic quality of the fermented foods, in texture, taste perception, mouth-feel and stability [153,155]. The above researchers reported that there is no information about the effects of bacterial EPS in non-dairy foods, such as meat products, sauerkraut and vinegar. Although EPS are tasteless, they prolong the time that the milk product spends in the mouth, enhancing its delicacy through an improved volatilization of the intrinsic flavors [153,155].

7.2. Applications of exopolysaccharides in the industry

In the last years, EPS derived from LAB have received increasing interest because of their GRAS status and their properties. EPS can improve the rheology of fermented foods (viscosity and elasticity) as natural biothickeners, emulsifiers, gelling agents and physical stabilizers to bind water and limit syneresis [153,156]. In particular commercial products like LAB dextran could be utilized apart from foods in gel filtration products, in the pharmaceutical industry, as blood volume expander and flow improver, in chemistry as paper and metal plating processes, in enhanced oil recovery and in chromographic media. Furthermore, levan can find use in the food industry as biothickener, while alteran as low-viscocity factor, extender, etc [128,151,157]. Additionally, EPS may produce oligosaccharides having prebiotic properties that could find important applications in functional foods [158]. The successful application of EPS in the manufacture of fermented milks is determined by the ability to bind water, interact with proteins and increase the viscosity of the milk serum phase [159]. Although, many LAB strains are able to produce EPS, their yield is low [149] and their industrial applications for the improvement of the properties of food products are limited [155].

7.3. Potential health benefits of exopolysaccharides

Apart from the technological benefits some EPS derived from LAB are claimed to have beneficial physiological effects on consumer’s health. These benefits are detectable at very low concentrations [153]. The EPS due to their increased viscosity in foods may remain for longer time in the gastrointestinal tract and therefore be beneficial to the transient colonization by probiotic bacteria [153,160]. Another health benefit is the generation of short chain fatty acids by colonic microflora degradation in the gut. Several of these fatty acids are possibly involved in the prevention of colon cancer [153,159]. In addition, LAB synthesized EPS appear to have anti-tumor, anti-ulcer, immuno-modulating and cholesterol-lowering activity [155].

7.4. Factors limiting the use of exopolysaccharides

The EPS used in the industry represent only a small fraction of the biopolymers used. The reasons are their economical production which needs a global knowledge of their biosynthesis and an adapted bioprocess technology [151]. Moreover, large scale production of LAB derived EPS is low, since LAB being anaerobes, are relatively inefficient in converting energy from carbohydrates, compared to aerobes [149,161]. So this technological barrier must be overcome for cost effective production of EPS. Furthermore, the genetic instability of EPS production is a problem to industrial applications, resulting in loss or reduction of production or change in the composition of EPS [162].

Increasing the knowledge on EPS structure may lead to the production of the “designer” EPS, including the modification primary in structure by altering their physical properties, their function and their production levels. However, for such production of EPS legal approval and the acceptance by the consumers and the food industries are required [151,163]. However, if these biomolecules are to be developed commercially, they must be cost effective.

7.5. Negative effects of exopolysaccharides

In some circumstances EPS cause food spoilage. For instance during the fermentation of wine or cider the final products receive undesirable properties. The EPS synthesis is responsible for dental plaque that results in dental caries. Moreover, the accumulation of EPS cause many technical and hygienic problems in the cheese and milk industries [156,164].


8. Lactic acid bacteria as source of low-calorie sweeteners

Recently, low calorie sugars produced from LAB have attracted the interest of researchers, industries and consumers, since they can find application as vital food ingredients mainly in foods marketed as “diabetic foods”, like sugar-free candies, cookies and chewing gums [165,166]. Manitol, sorbitol, xylitol, tagatose and thehalose are sweeteners produced by LAB. These substances are polyols, i.e. sugar alcohols and can be produced in food fermentation processes. They can be incorporated directly to foods or be produced in the food by LAB, leading to the production of foods containing such sweeteners [165]. Leuconostoc and Lactobacillus spp. seem to be the most promising producers of these sweeteners [167,168].

A number of health benefits have been attributed to these LAB produced low calories sweeteners, like low glycemic index, osmotic diuretics, weight control, antiplaque, prebiotic. These GRAS substances could be used especially by children, diabetic patients and weight watchers [165,166].


9. Conclusion

Lactic acid bacteria are very promising sources for novel products and applications, especially those that can satisfy the increasing consumer’s demands for natural products and functional foods. They can be used in the diet of humans and animals, with particular role in their health status. Despite recent advances, the study of LAB and their functional ingredients is still an emerging field of research that has yet to realize its full potential.


  1. 1. AureliP.CapursoL.CastellazziA. M.ClericiM.GiovanniniM.MorelliL.PoliA.PregliascoF.SalviniF.Zuccotti 2011 Probiotics And Health: An Evidence-based Review. Pharmacol. res. 63 366376 .
  2. 2. BarinovA.BolotinA.LangellaP.MaguinE.Van De Guchte 2011aguin E, Van De Guchte M (2011) Genomics Of The Genus Lactobacillus. In: Sonomoto K, Yokota A, editors. Lactic Acid Bacteria and Bifidobacteria: Current Progress in Advanced Research. Caister Academic Press, Portland, USA.
  3. 3. Stiles ME, Holzapfel WH 1997 Lactic Acid Bacteria Of Foods And Their Current Taxonomy. Int. j. food Microb. 36 129 .
  4. 4. Johnson-Green 2002 Introduction To Food Biotechnology. CRC Press, Boca Raton.
  5. 5. Halasz 2009 (2009) Lactic Acid Bacteria. In: Lasztity R, editor. Food Quality and Standards (3 . EOLSS Publishers Co Ltd, UK.
  6. 6. 2000ay J (2000) Modern Food Microbiology (6th edition). Aspen, Maryland
  7. 7. Hutkins RW 2006 Microbiology and Technology of Fermented Foods. Blackwell Publishing, Iowa, USA. 24
  8. 8. Teitelbaum JE, Walker WA 2002 Nutritional Impact Of Pre- and Probiotics As Protective Gastrointestinal Organisms. Annu. rev. nutr. 22 107138 .
  9. 9. Korhonen 2010 (2010) Antibiotic Resistance Of Lactic Acid Bacteria. Dissertations in Forestry and Natural Sciences, University of Eastern Finland.
  10. 10. Hamdan AM, Sonomoto 2011 (2011) Production Of Optically Pure Lactic Acid For Bioplastics. In: Sonomoto K, Yokota A, editors. Lactic Acid Bacteria and Bifidobacteria: Current Progress in Advanced Research. Caister Academic Press, Portland, USA.
  11. 11. Parker RB 1974 Probiotics, The Other Half Of The Antibiotic Story. Animal nutr. health. 29 48 .
  12. 12. Fuller 1989 (1989) Probiotics In Man And Animals. J. appl. bact. 66 365378 .
  13. 13. FAO/WHO- Food and Agriculture Organization / World Health Organization 2001 Health And Nutritional Properties Of Probiotics In Food Including Powder Milk With Live Lactic Acid Bacteria, Report Of A Joint FAO/WHO Expert Consultation On Evaluation Of Health And Nutritional Properties Of Probiotics In Food Including Powder Milk With Live Lactic Acid Bacteria, Cordoba. Argentina. foodsafety/ publications/ fs_management/ en/ probiotics.pdf. Accessed 2011 Dec 15.
  14. 14. O’May GA, Macfarlane GT 2005 Health Claims Associated With Probiotics. In: Tamime AY, editor. Probiotic Dairy Products. Blackwell Publishing, Oxford, UK.
  15. 15. KrishnakumarV.GordonI. R. 2001 Probiotics: Challenges And Opportunities. Dairy ind. Int. 66 3640 .
  16. 16. Playne MJ, Bennet LE, Smithers GW 2003 Functional Dairy Foods And Ingredients. Aust. J. dairy technol. 58 242264 .
  17. 17. Shah NP 2007 Functional Cultures And Health Benefits. Int. dairy j. 17 12621277 .
  18. 18. Avall-Jaaskelainen S, Palva A (2005) Lactobacillus Surface Layers And Their Applications. FEMS microbiol. rev. 29: 511-529.
  19. 19. Choi SS, Kang BY, Chung MJ, Kim SD, Park SH, Kim JS, Kang CY and Ha NJ 2005 Safety Assessment of Potential Lactic Acid Bacteria Bifidobacterium longum SPM1205 Isolated from Healthy Koreans. J. microbiol. 43 493498 .
  20. 20. Heller KJ 2001 Probiotic Bacteria In Fermented Foods: Product Characteristics And Starter Organisms. Am. j. clin. nutr. 73(S): 374S-379S.
  21. 21. ParvezS.MalikK. A.KangS. A.Kim 2006 Probiotics And Their Fermented Food Products Are Beneficial For Health. J. applied microbiol. 100 11711185 .
  22. 22. SoccolC. R.VandenbergheL. P. D. S.SpierM. R.MedeirosA. B. P.YamaguishiC. T.LindnenJ. D. D.PandeyA.Thomaz-Soccol 2010andenberghe LPDS, Spier MR, Medeiros ABP, Yamaguishi CT, Lindnen JDD, Pandey A, Thomaz-Soccol 2010 The Potential Of Probiotics: A Review. Food technol. biotechnol. 48: 413-434.
  23. 23. Ahmed 2003 (2003) Genetically Modified Probiotics In Foods. Trends biotechnol. 21 491497 .
  24. 24. Sanders ME 2009 How Do We Know When Something Called “Probiotic” Is Really A Probiotic? A Guideline For Consumers And Health Care Professionals. Functional Food Rev. 1 312 .
  25. 25. StantonC.GardinerG.MeehanH.CollinsK.FitzgeraldG.LynchP. B.RossR. P. 2001 Market Potentials For Probiotics. Am. j. clin. nutr. 73(S): 476483 .
  26. 26. BourliouxP.KoletzkoB.GuarnerF.Braesco 2003 The Intestine And Its Microflora Are Partners For The Protection Of The Host: Report In Danone Symposium The Intelligent Intestine. Am. j. clin. nutr. 78: 675-683.
  27. 27. Mazahreh AS, Ershidat OTM 2009 The Benefits Of Lactic Acid Bacteria In Yoghurt On The Gastrointestinal Function And Health. Pakistan j. nutr. 8 14041410 .
  28. 28. ShermanP. M.Johnson-HenryK. C.YeungH. P.NgoP. S. C.GouletJ.TompkinsT. A. 2005 Probiotics Reduce Enterohemorrhagic Escherichia Coli O157:H7- And Enteropathogenic E. Coli O127:H6-Induced Changes In Polarized T84 Epithelial Cell Monolayers By Reducing Bacterial Adhesion And Cytoskeletal Rearrangements. Infect. immun. 73 51835188 .
  29. 29. Lin CK, Tsai HC, Lin PP, Tsen HY, Tsai CC 2008 Lactobacillus Acidophilus LAP5 Able To Inhibit The Salmonella Cholerasuis Invasion To The Human Caco-2 Epithelial Cell. Anaerobe. 14 251255 .
  30. 30. O’SheaE. F.CotterP. D.StantonC.RossR. P.Hill 2012otter PD, Stanton C, Ross RP, Hill C (2012) Production Of Bioactive Substances By Intestinal Bacteria As A Basis For Explaining Probiotic Mechanisms: Bacteriocins And Conjugated Linoleic Acid. Int. J. Food Microbiol. 152 189205 .
  31. 31. WattsT.BertiI.SaponeA.GerarduzziT.NotT.ZielkeFasano. 2005, Gerarduzzi T, Not T, Zielke, Fasano A (2005) Role Of The Intestinal Tight Junction Modulator Zonulin In The Pathogenesis Of Type I Diabetes In BB Diabetic prone Rats. Proc. natl. acad. Sci. USA. 102 29162921 .
  32. 32. Meddings 2008 (2008) The Significance Of The Gut Barrier In Disease. Gut. 57 438440 .
  33. 33. Walker WA 2008 Mechanisms Of Action Of Probiotics. Clinic. inf. dis. 46(S2): S87.
  34. 34. Ng SC, Hart AL, Kamm MA, Stagg AJ, Knight SC 2009 Mechanisms Of Action Of Probiotics: Recent Advances. Inflamm. bowel dis. 15 300308 .
  35. 35. PerdigonG.AlvarezS.MedinaM.VintiniE.Roux 1999, Roux E (1999) Influence Of The Oral Administration Of Lactic Acid Bacteria On Iga Producing Cells Associated To Bronchus. Int. j. immunopathol. Pharmacol. 12 97102 .
  36. 36. Figueroa-GonzalezI.QuijanoG.RamirezG.Cruz-Guerrero 2011 Probiotics And Prebiotics- Perspectives And Challenges. J. sci. food agric. 91 13411348 .
  37. 37. Tannonck GW 2003 Probiotics: Time For A Dose Of Realism. Curr. i. intestinal microbiol. 4 3342 .
  38. 38. Vaz-Velho M, Todorov SD (2011) Potential Probiotic Evaluation OF Bacteriocin Producing Lactobacillus Plantarum ST16PA Isolated From Papaya (Carica Papaya). 12th ASEAN Food Conference, Bangkok, Thailand.
  39. 39. VilaB.Esteve-GarciaE.Brufau 2010 (2010) Probiotic Micro-organisms: 100 Years Of Innovation And Efficacy; Modes Of Action. World poult. Sci. 66 369380 .
  40. 40. FrizzoL. S.SotoL. P.ZbrunM. V.SignoriniM. L.BertozziE.SequeiraG.RodriguezArmesto. R.RosminiM. R. 2011 Effect Of Lactic Acid Bacteria And Lactose On Growth Performance And Intestinal Microbial Balance Of Artificially Reared Calves. Livestock sci. 140 246252 .
  41. 41. Thomas MR, Litin SC, Osmon DR, Corr AP, Weaver AL, Lohse CM 2001 Lack Of Effect Of Lactobacillus GG On Antibiotic-associated Diarrhea: A Randomized, Placebo-controlled Trial. Mayo Clinic Proc. 76 883889 .
  42. 42. IsolauriE.ArvolaT.SutasY.MoilanenE.Salminen 2000, Arvola T, Sutas Y, Moilanen E, Salminen E (2000) Probiotics in the management of atopic eczema. Clin. Experim. Allergy 30 16041610 .
  43. 43. KaurI. P.ChorpaK.Saini 2002 (2002) Probiotics: Potential Pharmaceutical Applications. Eur. j. pharmaceut. sci. 15 19 .
  44. 44. KruisW.FricP.PokrotnieksJ.LukasM.FixaB.KascakM.MAKammWeismueller. J.BeglinderC.StolteM.WolffC.Schulze 2004, Lukas M, Fixa B, Kascak M, Kamm MA, Weismueller J, Beglinder C, Stolte M, Wolff C, Schulze J (2004) Maintaining Remission Of Ulcerative Colitis With The Probiotic Escherichia Coli Nissle 1917 Is As Effective As With Standard Mesalazine. Gut 53 16171623 .
  45. 45. HenkerJ.MullerS.LaassM. W.SchreinerA.Schulze 2008, Muller S, Laass MW, Schreiner A, Schulze J (2008) Probiotic Echerichia Coli Nissle 1917(EcN) For Successful Remission Maintainance Of Ulcerative Colitis In Children and Adolescents: An Open-label Pilot Study. Z. Gastroenterol. 46 874875 .
  46. 46. ItsaranuwatP.Shal-haddadK.RobinsonP. K. 2003 The Potential Therapeutic Benefits Of Consuming ‘Health-Promoting’ Fermented Dairy Products: A Brief Update. Int. j. dairy technol. 56 203210 .
  47. 47. GillH.Prasad 2008 (2008) Bioactive Components Of Milk: Probiotics, Immunomodulation, And Health benefits. In: Bosze Z. Advances in Experimental Medicine and Biology. Springer, New York, USA. 423464 .
  48. 48. ReidG.CharbonneauD.ErbJ.KochanowskiB.BeuermanD.PoehnerR.BruceA. W. 2003 Oral Use Of Lactobacillus Rhamnosus GR-1 And L. Fermentum RC-14 Significantly Alters Vaginal Flora: Randomized Placebo-Controlled Trial In 64 Healthy Women. FEMS immunol. med. microbiol. 35 131134 .
  49. 49. ShornikovaA. V.CasasI. A.MykkanenH.SaloE.Vesikari 1997 (1997) Bacteriotherapy With Lactobacillus Reuteri In Rotavirus Gastroenteritis. Pediatric inf. dis. j. 16 11031107 .
  50. 50. GoelA. K.DilbaghiN.KambojD. V.Singh 2006 (2006) Probiotics: Microbial Therapy For Health Modulation. Defence sci. j. 56 513529 .
  51. 51. Liong MT, Shah NP 2005 Roles Of Probiotics And Prebiotics On Cholesterol: The Hypothesized Mechanisms. Nutrafood 4 4557 .
  52. 52. CavalliniD. C.BedaniR.BomdespachoL. Q.VendraminiR. C.RossiE. A. 2009 Effects Of Probiotic Bacteria, Isoflavoned And Simvastatin On Lipid Profile And Aherosclerosis In Cholesterol-fed Rabbits: A randomized Double-Blind Study. Lipids health dis. 8, Article 1.
  53. 53. HarishK.Varghese 2006 (2006) Probiotics In Humans- Evidence Based Review. Calicut med. j. 4: e3.
  54. 54. BombaA.NemcovaR.MudronovaD.Guba 2002 The Possibilities Of Potentiating The Efficacy Of Probiotics. Trends food sci. technol. 13: 121-126.
  55. 55. CremoniniF.Di CaroS.NistaE. C.BartolozziF.CapelliG.GasbariniG.Gasbarrini 2002 (2002) Meta-Analysis: The Effect Of Probiotic Administration On Antibiotic-Associated Diarrhoea. Aliment. pharmacol. ther. 16 14611467 .
  56. 56. SazawalS.HiremathG.DhingraU.MalikP.DebS.BlackR. E. 2006 Efficacy Of Probiotics In Prevention Of Acute Diarrhoea: A Meta-Analysis Of Masked, Randomized, Placebo-Controlled Trials. Lancet infect. dis. 6 374382 .
  57. 57. Yoon SS, Sun 2011 (2011) Probiotics, Nuclear Receptor Signaling, and Anti-Inflammatory Pathways. Gastroenterol. res. pract. 2011 Article ID: 971938.
  58. 58. Mallett AK, Bearne CA, Rowland IR 1989 The Influence Of Incubation Ph On The Activity Of Rat And Human Gut Flora Enzymes. J. appl. bacteriol. 66 433437 .
  59. 59. LaakeK.BjorneklettA.BakkaA. M.IdtvedtT.NorinK.EideT. J. 1999 Influence Of Fermented Milk On Clinical State, Faecal Bacterial Count And Biochemical Characteristics In Patient With Ileal-Pouch-Anal-Anastomosis. Microb. ecol. health dis. 11 211217 .
  60. 60. Gosselink MP, Schouten WR, Van Lieshout LM, Hop WC, Laman JD, Ruseler-Van Embden JG 2004 Delay Of The First Onset Of Pouchitis By Oral Intake Of The Probiotic Strain Lactobacillus Rhamnosus GG. Dis. Colon rectum. 47 876884 .
  61. 61. PranteraC.ScribanoM. L.FalascoG.AndreoliA.Luzi 2002, Scribano ML, Falasco G, Andreoli A, Luzi C (2002) Ineffectiveness Of Probiotics In Preventing Recurrence After Curative Resection For Crohn’s Disease: A Randomized Controlled Trial With Lactobacillus GG. Gut 51 405409 .
  62. 62. HunterJ.LeeA.KingT.BarrattM.LinggoodM.Blades 1996, Lee A, King T, Barratt M, Linggood M, Blades J (1996) Enterococcus Faecium Strain PR88 - An Effective Probiotic. Gut 38(S1), A62.
  63. 63. NiedzielinK.KordeckiK.Kosik 1998 (1998) New Possibility In The Treatment Of Irritable Bowel Syndrome: Probiotics As A Modification Of The Microflora Of The Colon. Gastroenterology 114: A402.
  64. 64. Brady LJ, Gallaher DD, Busta FF 2000 The Role Of Probiotic Cultures In The Prevention Of Colon Cancer. The j. nutr. 130(2S): 410S-455S.
  65. 65. RafterJ. 2003 Probiotics And Colon Cancer. Best Pract. Res. Clin. Gastroenterol. 17 849859 .
  66. 66. Hamilton-Miller JM 2003 The role of probiotics in the treatment and prevention of Helicobacter pylori infection. Int. j. antimicrob. agents. 22 360366 .
  67. 67. CatsA.KulpersE. J.MABosschaertPot. R. G.Vandenbroucke-GaulsC. M.KustersJ. G. 2003 Effect Of Frequent Consumption Of Lactobacillus Casei-Containing Milk Drink In Helicobacter Pylori-Colonised Subjects. Pharmacol. therap. 17 429435 .
  68. 68. 2001, Schrezenmeir J (2001) Protection From Gastrointestinal Diseases With The Use Of Probiotics. Am. j. clin. nutr. 73: 430S-436S.
  69. 69. SaltzmanJ. R.RussellR. M.GolnerB.BarakatS.DallalG. E.GoldinB. R. 1999 A Randomized Trial Of Lactobacillus Acidophilus BG2FO4 To Treat Lactose Intolerance. Am. j. clin. nutr. 69 1406 .
  70. 70. Roberfroid MB 2000 Prebiotics And Probiotics: Are They Functional Foods? Am. j. clin. nutr. 71(S): 1682S-1687S.
  71. 71. PessiT.SutasY.HurmeM.Isolauri 2000 (2000) Interleukin-10 Generation In Atopic Children Following Oral Lactobaccilus Rhamnosus GG. Clin. experim. Allergy. 30 18041808 .
  72. 72. ReidG.BruceA. W.FraserN.HeinemannC.OwenJ.Henning 2001ruce AW, Fraser N, Heinemann C, Owen J, Henning B (2001) Oral Probiotics Can Resolve Urogenital Infections. FEMS immunol. med. microbiol. 30 4952 .
  73. 73. De VreseM.Schrezenmeis 2002 (2002) Probiotics And Non-Intestinal Infectious Conditions. Br. j. nutr. 88(S1): S5966 .
  74. 74. SuzukiI.NomuraM.MorichiT. 1991 Isolation Of Lactic Acid Bacteria Which Suppress Mold Growth And Show Antifungal Action. Milchwissenschaft, 46 635639 .
  75. 75. Florianowicz 2001 (2001) Antifungal Activity Of Some Microorganisms Against Penicillium Expansum. Eur. food res. technol. 212 282286 .
  76. 76. MandaiV.SenS. K.MandaiN. C. 2007 Detection, Isolation And Partial Characterization Of Antifungal Compound(S) Produced By Pediococcus Acidilactici LAB 5. Nat. prod. commun. 2 671674 .
  77. 77. Sathe SJ, Nawani NN, Dhakephalkar PK, Kapadnis BP 2007 Antifungal Lactic Acid Bacteria With Potential To Prolong Shelf-Life Of Fresh Vegetables. J. appl. microbiol. 103 26222628 .
  78. 78. Gerez CL, Torino MI, Rollan G, Font de Valdez G (2009) Prevention Of Bread Mould Spoilage By Using Lactic Acid Bacteria With Antifungal Properties. Food Control. 20: 144-148.
  79. 79. Kankaanpaa P, Tuomola E, El-Nezami H, Ahokas J, Salminen SJ (2000) Binding Of Aflatoxin B1 Alters The Adhesion Properties Of Lactobacillus Rhamnosus Strain GG In Caco-2 Model. J. food prot. 63: 412–414.
  80. 80. DeshpandeG.RaoS.Patole 2011, Patole S (2011) Progress In The Field Of Probiotics: Year 2011. Curr. Opin. Gastroenterol. 27 1318 .
  81. 81. ChenF.Wang 2010 (2010) Novel Technologies For The Prevention And Treatment Of Dental Caries: A Patent Survey. Expert. opin. Ther. Pat. 20 681694 .
  82. 82. Flichy-FernandezA. J.Alegre-DiagoT.Penarrocha-OltraD.Penarrocha-Diago 2010 Probiotic Treatment In The Oral Cavity: An Update. Med. oral patol. oral cir. bucal. 15: e677680 .
  83. 83. Wood BJB, Holzapfel WH 1995 The Genera of Lactic Acid Bacteria. London, Blackie Academic & Professional, UK.
  84. 84. Leroy F, De Vuyst L (2004) Lactic Acid Bacteria As Functional Starter Cultures For The Food Fermentation Industry. Trends food sci. technol. 15: 67-78.
  85. 85. De VuystL.Leroy 2007 (2007) Bacteriocins From Lactic Acid Bacteria: Production, Purification, And Food Applications. J. mol. Microbiol. biotechnol. 13 194199 .
  86. 86. Ray 1992 (1992) The Need For Food Biopreservation. In: Ray B, Daeschel M, editors. Food biopreservatives of microbial origin Boca Raton, Florida: CRC Press. 123 .
  87. 87. CapliceE.FitzgeraldG. 1999itzgerald G F (1999) Food Fermentations: Role Of Microorganisms In Food Production And Preservation. Int.j food microbiol. 50 131149 .
  88. 88. Sandine WE 1996 Commercial Production Of Dairy Starter Cultures. In: Cogan TM, Accolas JP, editors. Dairy Starter Cultures. Wiley-VCH. New York, USA. 191206 .
  89. 89. 1995LJ, Gaya P, Nunez, M (1995) Isolation Of Tyrosin Decarboxylaseless Mutants Of A Bacteriocin-Producing Enterococcus Faecalis Strain And Their Application In Cheese. J food prot. 58 12221226 .
  90. 90. Metchnikoff II, Chalmer Mitchell 1910 Nature Of Man Or Studies In Optimistic Philosophy. Kessinger Publishing, Whitefish, MT, USA.
  91. 91. Hansen EB 2002 Commercial Bacterial Starter Cultures For Fermented Food Of The Future. Int. j. food microbiol. 78 119131 .
  92. 92. TamineA. Y.SaarelaM.KorslundSondergaard. A.MistryV. V.ShahN. P. 2005 Production And Maintenance Of Viability Of Probiotic Micro-organisms In Dairy Products. In: Tamine AY, editor. Probiotic Dairy Products. Blackwell Publishing Ltd, Oxford, UK. 3972 .
  93. 93. Aragon-Alegro LC, Alarcon-Alegro JH, Cardarelli HR, Chiu MC, Sadd SMI 2007 Potentially Probiotic And Symbiotic Chocolate Mousse. LWT-Food sci. technol. 40 669675 .
  94. 94. ConlinP. R.ChowD.MillerE. R.SvetkeyL. P.LinP. H.HarshaD. W.MooreT. J.SacksF. M.AppelL. J. 2000 The Effect Of Dietary Patterns On Blood Pressure Control In Hypertensive Patients: Results From The Dietary Approaches To Stop Hypertension (DASH) Trial. Am. j. hypertension 13 949955 .
  95. 95. Karma BKL, Emata OC, Barraquio VL 2007 Lactic Acid And Probiotic Bacteria From Fermented And Probiotic Dairy Products. Sci. Diliman. 19: 23_34.
  96. 96. Erkkila 2001 (2001) Bioprotective And Probiotic Meat Starter Cultures For The Fermentation Of Dry Sausages. Academic Dissertation, Department of Food Technology, University of Helsinki, Finland.
  97. 97. Ammor MS, Mayo 2007 (2007) Selection Criteria For Lactic Acid Bacteria To Be Used As Functional Starter Cultures In Dry Sausage Production: An Update. Meat sci. 76 138146 .
  98. 98. ZhangW.XiaoS.SamaraweeraH.LeeE. J.AhnD. U. 2010 Improving Functional Value Of Meat Products. Meat Sci. 86 1531 .
  99. 99. TodorovS. D.FurtadoD. N.SaadS. M. I.TomeE.FrancoB. D. G. M. 2011 Potential Beneficial Properties Of Bacteriocin-producing Lactic Acid Bacteria Isolated From Smoked Salmon. J. appl. microbiol. 110 971986 .
  100. 100. GeversD.DanielsenM.HuysG.Swings 2003 (2003) Molecular Characterization Of Tet(M) Genes In Lactobacillus Isolates From Different Types Of Fermented Dry Sausage. Appl. Environm. Microbiol. 69 12701275 .
  101. 101. SuzziG.Gardini 2003 (2003) Biogenic Amines In Dry Fermented Sausages: A Review. Int.j. food microbiol. 88 4154 .
  102. 102. BuruleanuL.NicolescuC. L.BratuM. G.ManeaI.Avram 2010 (2010) Study regarding some metabolic features during lactic acid fermentation of vegetable juices. Romanian biotechnol. Letters. 15 51775188 .
  103. 103. Fleming HP 1984 Development In Cucumber Fermentation. Solid State Fermentation Symposium, London, UK. 241252 .
  104. 104. Medina E, Gori C, Servili M, de Castro A, Romero C, Brenes M (2010) Main Variable Affecting The Lactic Acid Fermentation Of Table Olives. Int. j. food sci. tech. 45: 1291-1296.
  105. 105. WeinbergZ. G.AshbellG.HenY.Azrieli 1993shbell G, Hen Y, Azrieli A (1993) The Effect Of Applying Lactic Acid Bacteria At Ensiling On The Aerobic Stability Of Silages. J. applied bacteriol. 75 512518 .
  106. 106. BrobergA.JacobssonJ.StromK.Schnurer 2007acobsson J, Strom K, Schnurer J (2007) Metabolite Profiles Of Lactic Acid Bacteria In Grass Silage. Applied environm. microbiol. 73 55475552 .
  107. 107. Mc DonaldP.HendersonA. R.HeronS. J. E. 1991 The Biochemistry Of Silage, 2nd ed. Chalcombe Publications, Aberystwyth, UK. 184236 .
  108. 108. WeinbergZ. G.MuckR. E.WeimerP. J.ChenY.Gamburg 2004uck RE, Weimer PJ, Chen Y, Gamburg M (2004) Lactic Acid Bacteria Used In Inoculants For Silage As Probiotics For Ruminants. Appl. biochem. biotechnol. 118 19 .
  109. 109. GillorO.EtzionA.MARiley 2008 The Dual Role Of Bacteriocins As Anti- And Probiotics. Appl. microbiol. biotechnol. 81 591606 .
  110. 110. LavermicoccaP.ValerioF.EvidenteA.LazzaroniS.CorsettiA.Gobbetti 2000 (2000) Purification And Characterization Of Novel Antifungal Compounds From The Sourdough Lactobacillus Plantarum Strain 21B. Appl. environ. microbiol. 66 40844090 .
  111. 111. Falagas ME, Betsi GI, Athanasiou 2007 (2007) Probiotics For The Treatment Of Women With Bacterial Vaginosis. Clin. microbiol. infect. 13 657664 .
  112. 112. RajaramG.ManivasaganP.ThilagavathiB.Saravanakumar 2010 (2010) Purification And Characterization Of A Bacteriocin Produced By Lactobacillus Lactis Isolated From Marine Environment. Adv. j. food sci. technol. 2 138144 .
  113. 113. Surwase SS, Adsul GG, Jadhav DS 2011 Anti-microbial Activity Associated With Bacteriocin From Lactobacillus Acidophilus. J. res. antimicrob. 1 58 .
  114. 114. DobsonA.CotterP. D.RossR. P.Hill 2012otter PD, Ross RP, Hill C (2012) Bacteriocin Production: A Probiotic Trait? Appl. Environ. Microbiol. 78 16 .
  115. 115. KosB.BeganovicJ.JurasicL.SvadumovicM.PavuncA. L.UroicK.Suskovic 2003, Jurasic L, Svadumovic M, Pavunc AL, Uroic K, Suskovic J (2003) Coculture-Inducible Bacteriocin Biosynthesis Of Different Probiotic Strains By Dairy Starter Culture Lactococcus Lactis. Mljekarstvo 61 273282 .
  116. 116. SavadogoA.OuattaraC. A. T.BassoleI. H. N.ASTraore 2006 Bacteriocins And Lactic Acid Bacteria- A Minireview. African J. Biotechnol. 5 678683 .
  117. 117. GordonD. M.OliverE.Littlefield-Wyer 2007 (2007) The Diversity Of Bacteriocins In Gram-Negative Bacteria. In: Riley MA, Chavan M, editors. Bacteriocins: Ecology and evolution. Springer, Berlin, Germany. 518 .
  118. 118. Heng NCK, Wescombe PA, Burton JP, Jack RW, Tagg JR 2007 The diversity of bacteriocins in Gram-positive bacteria. In: Riley MA, Chavan M, editors. Bacteriocins: Ecology and evolution. Springer, Berlin, Germany. 4592 .
  119. 119. ZendoT.Sonomoto 2011 (2011) Classification And Diversity Of Bacteriocin. In: Sonomoto K, Yokota A, editors. Lactic Acid Bacteria and Bifidobacteria: Current Progress in Advanced Research. Caister Academic Press, Portland, USA.
  120. 120. Dobson AE, Sanozky-Dawes RB, Klaenhammer TR 2007 Identification Of An Operon Inducing Peptide Involved In The Production Of Lactacin B By Lactobacillus Acidophilus. J. appl. microbiol. 103 17661778 .
  121. 121. CintasL. M.CasausM. P.HerranzC.NesI. F.HernandezP. E. 2001 Review: Bacteriocins Of Lactic Acid Bacteria. Food sci. tech. int. 7 281305 .
  122. 122. JuodeikieneG.BartkieneE.ViskelisP.UrbonavicieneD.EidukonyteD.Bobinas 2012 (2012) Fermentation processes using lactic acid bacteria producing bacteriocins for preservation and improving functional properties of food products. In: Petre M, editor. Advances in applied biotechnology. Intech, Croatia. 63100 .
  123. 123. GalvezA.AbriouelH.LopezR. L.OmarN. B. 2007 Bacteriocin-Based Strategies For Food Biopreservation. Int. j. food microbiol. 120 5170 .
  124. 124. Beasley SS, Saris PEJ 2004 Nisin-producing Lactococcus Lactic Strains Isolated From Human Milk. Appl. environ. microbiol. 70 50515053 .
  125. 125. DeeganL. H.CotterP. D.HillC.Ross 2006D, Hill C, Ross 2006 Bacteriocins: Biological Tools For Bio-Preservation And Shelf-Life Extension. Int. dairy j. 16: 1058-1071.
  126. 126. Parada JL, Caron C2007, Medeiros ABP, Soccol R (2007) Bacteriocins From Lactic Acid Bacteria: Purification, Properties And Use As Biopreservatives. Brazilian arch. biol. technol. 50 521542 .
  127. 127. Bonos EM, Christaki EV, Florou-Paneri PC 2010 Performance And Carcass Characteristics Of Japanese Quail As Affected By Sex Or Mannan Oligosaccharides And Calcium Propionate. South African j. animal sci. 40 173184 .
  128. 128. O’ConnorE. B.BarrettE.FitzgeraldG.HillC.StantonC.RossR. P. 2005 Production Of Vitamins, Exopolysaccharides And Bacteriocins By Probiotic Bacteria. In: Tamime AY, editor. Probiotic Dairy Products. Blackwell Publishing, Oxford, UK.
  129. 129. Le BlancJ. G.LainoJ. E.Juarez delValle. M.VanniniV.van SinderenD.TarantoM. P.Font deValdez. G.Savoy deGiori. G.Sesma 2011 B-Group Vitamin Production By Lactic Acid Bacteria- Current Knowledge And Potential Applications. J. applied microbiol. 111 12971309 .
  130. 130. Le BlancJ. GioriG. S.SmidE. J.HugenholtzJ.Sesma 2007 (2007) Folate Production By Lactic Acid Bacteria And Other Food-Grade Microorganisms. Commun. curr. res. educ. top. trends appl. microbiol. 1 329339 .
  131. 131. Eitenmiller RR, Landen WO 1999 Folate. In: Eitenmiller RR, Landen WO, editors. Vitamin Analysis For The Health And Food Sciences. CRC Press LLC, Boca Raton. 411465 .
  132. 132. WoutersJ. T. M.AyadE. H. E.HugenholtzJ.Smit 2002 (2002) Microbes From Raw Milk For Fermented Dairy Products. Int. dairy j. 12 91109 .
  133. 133. RossiM.AmarettiA.Raimondi 2011 (2011) Folate Production By Probiotic Bacteria. Nutrients 3 118134 .
  134. 134. Quesada-Chanto A, Afschar AS, Wagner F (1994) Microbial Production Of Propionic Acid And Vitamin B12 Using Molasses Or Sugar. App. microbiol. biotechnol. 41: 378-383.
  135. 135. 2003, Sesma F (2003) Lactobacillus Reuteri CRL1098 Produces Cobalamin. J. bacteriol. 185 56535647 .
  136. 136. Molina V, Medici M, Taranto MP, Font de Valdez G (2008) Effects Of Maternal Vitamin B12 Deficiency From End Of Gestation To Weaning On The Growth And Haematological And Immunological Parameters In Mouse Dams And Offspring. Arch. anim. nutr 62: 162–168.
  137. 137. Olson RE 1984 The Function And Metabolism Of Vitamin K. Ann. rev. nutr. 4 281337 .
  138. 138. MorishitaT.TamuraN.MakinoT.Kudo 1999 (1999) Production Of Menaquinones By Lactic Acid Bacteria. J. dairy sci. 82 18971903 .
  139. 139. Wilson JA 1983 Disorders Of Vitamins: Deficiency, Excess And Errors Of Metabolism. In: Petersdorf RG, Harrison TR. Harrison’s Principles of Internal Medicine. McGraw-Hill Book Co. New York, USA. 461470 .
  140. 140. Capozzi V, Menga V, Digesu AM, De Vita P, van Sinderen D, Cattivelli L, Fares C, Spano G (2011) Biotechnological Production Of Vitamin B2-Enriched Bread And Pasta. J. agric. food chem. 59: 8013–8020.
  141. 141. Naidu AS, Bidlack WR, Clemens RA 1999 Probiotic Spectra of Lactic Acid Bacteria (LAB). Crit. rev. food sci. nutr. 38 13126 .
  142. 142. Tamang JP (2011) Prospects Of Asian Fermented Foods In Global Markets. 11th ASEAN Food Conference, Bangkok, Thailand.
  143. 143. MatthewsA.GrimaldiA.WalkerM.BartowskyE.GrbinP.Jiranek 2004 Lactic Acid Bacteria As A Potential Source Of Enzymes For Use In Vinification. Appl. environ. mcrobiol. 70: 5715-5731.
  144. 144. Mtshali PS 2007 Screening And Characterisation Of Wine-related Enzymes Produced By Wine-associated Lactic Acid Bacteria. MSc. Thesis, Stellenbosch University.
  145. 145. MogensenG. 1993 Starter Cultures. In: Smith J, editor. Technology of reduced-additive foods London: Blackie Academic & Professional, UK. 125 .
  146. 146. GuldfeldtL. U.SorensenK. I.StromanP.BehrndtH.WilliamsD.JohansenE. 2001 Effect Of Starter Cultures With A Genetically Modified Peptidolytic Or Lytic System On Cheddar Cheese Ripening. Int. dairy j. 11 373382 .
  147. 147. GonzalezL.SacristanN.ArenasR.FresnoJ. M.METornadijo 2010 Enzymatic Activity Of Lactic Acid Bacteria (With Antimicrobial Properties) Isolated From A Traditional Spanish Cheese. Food microbiol. 27 592597 .
  148. 148. Ganzle MG, Schwab 2009 (2009) Ecology Of Exopolysaccharide Formation By Lactic Acid Bacteria: Sucrose Utilisation, Stress Tolerance, And Biofilm Formation. In: Ullrich M, editor. Bacterial Polysaccharides: Current Innovations And Future Trends: Caister Academic Press, Bremen, Germany.
  149. 149. Ruas-MadiedoP.HugenholtzJ.Zoon 2002, Hugenholtz J, Zoon 2002 An Overview Of The Functionality Of Exopolysaccharides Produced By Lactic Acid Bacteria. Int. dairy j. 12: 163-171.
  150. 150. los-GavilanReyes. 2009 Biosynthesis and Chemical Composition Of Exopolysaccharides Produced By Lactic Acid Bacteria. In: Ullrich M, editor. Bacterial Polysaccharides: Current Innovations And Future Trends: Caister Academic Press, Bremen, Germany.
  151. 151. De VinF.VaningelgemF.Degeest 2001 (2001) Recent Developments In The Biosynthesis And Applications Of Heteropolysaccharides From Lactic Acid Bacteria. Int. dairy j. 11 687707 .
  152. 152. Monsan P, Bozonnet S, Albenne C, Jouela G, Willemot RM, Remaud-Simeon M (2001) Homopolysaccharides From Lactic Acid Bacteria. Int. dairy j. 11: 675-685.
  153. 153. DubocP.Mollet 2001 (2001) Application Of Exopolysaccharides In The Dairy Industry. Int. dairy j. 11 759768 .
  154. 154. WaldherrF.VogelR. F. 2009 Commercial Exploitation Of Homo-exopolysaccharides In Non-dairy Food Systems. In: Ullrich M, editor. Bacterial Polysaccharides: Current Innovations And Future Trends: Caister Academic Press, Bremen, Germany.
  155. 155. Zhang Y, Li S, Zhang C, Luo Y, Zhang H, Yang Z (2011) Growth And Exopolysaccharide Production By Lactobacillus Fermentum F6 In Skim Milk. African j. biotechnol. 10: 2080-2091.
  156. 156. De VuystL.Degeest 1999 (1999) Heteropolysaccharides From Lactic Acid Bacteria. FEMS microbiol. rev. 23 153177 .
  157. 157. FreitasF.AlvesV. D.ReisA. M. 2011 Advances In Bacterial Exopolysaccharides: From Production To Biotechnological Applications. Trends biotechnol. 29 388398 .
  158. 158. GibsonR.RoberfroidM. B. 1995 Dietary Modulation Of The Human Colonic Microbiota: Introducing The Concept Of Prebiotics. J. nutr. 125 14011412 .
  159. 159. RuijssenaarsH. J.StingeleF.Hartmans 2000tingele F, Hartmans S (2000) Biodegradability Of Food-associated Extracellular Polysaccharides. Curr. microbiol. 40 194199 .
  160. 160. GermanB.SchiffrinE.RenieroR.MolletB.PfeiferA.NeeserJ. R. 1999 The development of functional foods: Lessons from the gut. Trends biotechnol. 17 492499 .
  161. 161. Welman AD, Maddox IS 2003 Exopolysaccharides From Lactic Acid Bacteria: Perspectives And Challenges. Trends biotechnol. 21 269274 .
  162. 162. BouzarF.CerningJ.Desmazeaud 1996 (1996) Exopolysaccharide Production In Milk By Lactobacillus Delbrueckii Ssp. Bulgaricus CNRZ 1187 And By Two Colonial Variants. J. dairy sci. 79 205211 .
  163. 163. Sutherland IW 1999 Polysaccharases For Microbial Exopolysaccharides. Carbohydr. polym. 38 319328 .
  164. 164. PatelS.MajumderA.Goyal 2012, Goyal A (2012) Potentials Of Exopolysaccharides From Lactic Acid Bacteria. Indian j. microbiol. 52 312 .
  165. 165. PatraF.TomarS. K.Arora 2009K, Arora S (2009) Technological And Functional Applications Of Low-Calorie Sweeteners From Lactic Acid Bacteria. J. food sci. 74 1621 .
  166. 166. MonederoV.Perez-MartínezG.MJYebra 2010 Perspectives Of Engineering Lactic Acid Bacteria For Biotechnological Polyol Production. Appl. microbiol. biotechnol. 86 10031015 .
  167. 167. Soetaert 1990 (1990) Production Of Mannitol With Leuconostoc Mesenteroides. Med. fac landbouwwet rijksuniv gent. 55 154952 .
  168. 168. Kim 2004 Current Studies On Biological Tagatose Production Using L-Arabinose Isomerase: A Review And Future Perspective. Appl. microbiol. biotechnol. 65: 243-249.

Written By

Panagiota Florou-Paneri, Efterpi Christaki and Eleftherios Bonos

Submitted: 16 November 2011 Published: 30 January 2013